Dr. Jonathan Javitt, CEO of NRx Pharmaceuticals, and Anne Dunsmore, Founder of Angel Force USA, discuss their joint mission to prevent veteran suicide through advanced neuroplastic therapies and nationwide awareness programs.
Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, presents at Noble Capital Markets Virtual Emerging Growth Conference.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
AdvisorShares is an institutional investor and holder of NRXP stock.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
AdvisorShares is an institutional investor and holder of NRXP stock.
Interview discusses NRx Pharmaceuticals’ game-changing approach to mental health treatment.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
AdvisorShares is an institutional investor and holder of NRXP stock.
NRX-100 is an IV ketamine formulation being submitted to regulators as an alternative treatment for acute suicidal crises in certain types of depression.
Kadima Neuropsychiatry Institute, featured in the documentary (begins around the 24 minute mark of the documentary), has been identified as a planned HOPE Flagship Clinic acquisition.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
AdvisorShares is an institutional investor and holder of NRXP stock.
